Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.46% | 179.18 | 1.2% | $610.69m | |
| CELG | Celgene Corporation | 1.20% | 77.53 | 1.2% | $572.07m | |
| GILD | Gilead Sciences, Inc. | 0.35% | 68.07 | 0.9% | $552.90m | |
| BIIB | Biogen Inc. | 1.40% | 283.61 | 1.2% | $527.93m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.05% | 294.84 | 2.6% | $308.71m | |
| ILMN | Illumina, Inc. | 0.13% | 271.16 | 3.5% | $235.67m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.06% | 156.19 | 1.9% | $230.29m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.92% | 117.92 | 2.0% | $222.86m | |
| A | Agilent Technologies, Inc. | -0.49% | 64.52 | 1.5% | $209.71m | |
| NKTR | Nektar Therapeutics | 0.04% | 81.98 | 6.0% | $198.38m | |
| INCY | Incyte Corporation | 0.23% | 66.71 | 2.5% | $177.04m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.88% | 88.44 | 16.6% | $123.92m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.99% | 89.36 | 4.4% | $119.68m | |
| EXAS | Exact Sciences Corporation | -3.30% | 51.24 | 25.5% | $112.24m | |
| BLUE | Bluebird Bio, Inc. | 1.62% | 188.65 | 15.7% | $96.25m |
Company Profile
Loxo Oncology, Inc. is a biopharmaceutical company, which develops small molecule therapeutics for the treatment of cancer. Its pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat the cancer with dramatic effect. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.